Case Report
Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
Table 2
Baseline patient characteristics and clinical/PSA failure status for patients with immunologic data and node positive disease.
| | Patient # | Age at diagnosis (years) | Clinical stage | Gleason score | PSA at diagnosis (g/L) | Total dose radiation (Gy) | Clinical/PSA failure |
| | 1 | 51 | T2bN1M0 | 7 | 95 | 75.6 | No | | 2 | 56 | T2cN1M0 | 9 | 5 | 70.2 | Yes | | 3 | 56 | T2cN1M0 | 8 | 63 | 68.0 | Yes | | 4 | 55 | T2aN1M0 | 8 | 19 | 75.6 | Yes |
|
|
